GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo Global Exchange(s) Pte Ltd (OTCPK:IGEX) » Definitions » EV-to-EBIT

Indo Global Exchange(s) Pte (Indo Global Exchange(s) Pte) EV-to-EBIT : 1,129.00 (As of May. 25, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Indo Global Exchange(s) Pte EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Indo Global Exchange(s) Pte's Enterprise Value is $3.39 Mil. Indo Global Exchange(s) Pte's EBIT for the trailing twelve months (TTM) ended in Oct. 2017 was $0.00 Mil. Therefore, Indo Global Exchange(s) Pte's EV-to-EBIT for today is 1,129.00.

The historical rank and industry rank for Indo Global Exchange(s) Pte's EV-to-EBIT or its related term are showing as below:

IGEX' s EV-to-EBIT Range Over the Past 10 Years
Min: 0   Med: 0   Max: 1295.67
Current: 1212.33

During the past 10 years, the highest EV-to-EBIT of Indo Global Exchange(s) Pte was 1295.67. The lowest was 0.00. And the median was 0.00.

IGEX's EV-to-EBIT is not ranked
in the Drug Manufacturers industry.
Industry Median: 16.985 vs IGEX: 1212.33

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Indo Global Exchange(s) Pte's Enterprise Value for the quarter that ended in Oct. 2017 was $0.00 Mil. Indo Global Exchange(s) Pte's EBIT for the trailing twelve months (TTM) ended in Oct. 2017 was $0.00 Mil. Indo Global Exchange(s) Pte's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2017 was %.


Indo Global Exchange(s) Pte EV-to-EBIT Historical Data

The historical data trend for Indo Global Exchange(s) Pte's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo Global Exchange(s) Pte EV-to-EBIT Chart

Indo Global Exchange(s) Pte Annual Data
Trend Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14 Jul15 Jul16 Jul17
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,220.88 -1.29 - - -

Indo Global Exchange(s) Pte Quarterly Data
Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Indo Global Exchange(s) Pte's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Indo Global Exchange(s) Pte's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indo Global Exchange(s) Pte's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indo Global Exchange(s) Pte's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Indo Global Exchange(s) Pte's EV-to-EBIT falls into.



Indo Global Exchange(s) Pte EV-to-EBIT Calculation

Indo Global Exchange(s) Pte's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3.387/0.003
=1,129.00

Indo Global Exchange(s) Pte's current Enterprise Value is $3.39 Mil.
Indo Global Exchange(s) Pte's EBIT for the trailing twelve months (TTM) ended in Oct. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indo Global Exchange(s) Pte  (OTCPK:IGEX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Indo Global Exchange(s) Pte's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2017 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Oct. 2017 ) =EBIT / Enterprise Value (Q: Oct. 2017 )
=0.003/0
= %

Indo Global Exchange(s) Pte's Enterprise Value for the quarter that ended in Oct. 2017 was $0.00 Mil.
Indo Global Exchange(s) Pte's EBIT for the trailing twelve months (TTM) ended in Oct. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indo Global Exchange(s) Pte EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Indo Global Exchange(s) Pte's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Indo Global Exchange(s) Pte (Indo Global Exchange(s) Pte) Business Description

Traded in Other Exchanges
N/A
Address
6400 S. Fiddlers Green, No. 250 No.1012, Greenwood Village, CO, USA, 80111
Indo Global Exchange(s) Pte Ltd is a holding company. The company is focusing on developing assets within the pharmaceutical and nutraceutical industries.